Sangal PapersBOM:516096 -4.27%61 EBITDA Margin % is 6.56% as of Mar. 2026, which is 58% above its 10-year median of 4.16. GuruFocus rates BOM:516096 with a GF Score™ of 61/100 and a GF Value™ of ₹182.32 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 283 Forest Products companies, Sangal Papers ranks worse than 62.9% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Sangal Papers's EBITDA for the
three
months ended in Mar. 2026 was ₹24 Mil. Sangal Papers's Revenue for the
three
months ended in Mar. 2026 was ₹367 Mil. Therefore, Sangal Papers's EBITDA margin for the quarter that ended in Mar. 2026 was 6.56%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Sangal Papers EBITDA Margin % Related Terms
Sangal Papers EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Sangal Papers's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Paper & Paper Products subindustry, Sangal Papers's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sangal Papers EBITDA Margin % vs Forest Products Industry
For the Forest Products industry and Basic Materials sector, Sangal Papers's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Sangal Papers's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sangal Papers (BOM:516096) has a EBITDA Margin % of 6.56% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Sangal Papers and its competitors. This is 58% above median its historical median of 4.16. Over the past decade, Sangal Papers' EBITDA Margin % has ranged from 3.30 to 6.88. According to the industry distribution chart, Sangal Papers ranks #178 out of 283 companies in the Forest Products industry, placing it in the top 62.9%.
Is Sangal Papers' EBITDA Margin % too high?
Sangal Papers' current EBITDA Margin % of 6.56% is 58% above median its 10-year median of 4.16. Over the past 10 years, this metric has ranged from a low of 3.30 to a high of 6.88. The Forest Products industry median EBITDA Margin % is 6.78. Sangal Papers' value of 6.56% is 3.2% below this industry median. Based on the distribution chart, Sangal Papers ranks #178 out of 283 companies in the Forest Products industry, which is below the industry midpoint. Overall, Sangal Papers has a GF Score™ of 61/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sangal Papers' EBITDA Margin % compare to competitors?
According to the Forest Products industry distribution chart, Sangal Papers ranks #178 out of 283 companies for EBITDA Margin %. This places Sangal Papers in the lower half of its industry. The industry median EBITDA Margin % is 6.78. Sangal Papers' value of 6.56% is 3.2% below this benchmark. Historically, Sangal Papers' own EBITDA Margin % has ranged from 3.30 to 6.88 over the past decade. While the company's 10-year median is 4.16 vs. the industry median of 6.78, Sangal Papers has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Forest Products company?
The median EBITDA Margin % among Forest Products companies is 6.78, based on 283 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sangal Papers's current EBITDA Margin % of 6.56% is 3.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Sangal Papers and its competitors. For the Forest Products industry, the median EBITDA Margin % is 6.78 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sangal Papers's current EBITDA Margin % is 6.56%, which is 58% above median its own 10-year median of 4.16. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sangal Papers stock overvalued right now?
Based on GuruFocus' analysis, Sangal Papers (BOM:516096) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹182.32, compared to a current price of ₹154.80 — trading 15.1% below its estimated fair value. The current EBITDA Margin % is 6.56%, which is 58% above median its 10-year median of 4.16 and 3.2% below the Forest Products industry median of 6.78. Sangal Papers' overall GF Score™ is 61/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Sangal Papers (BOM:516096), the current EBITDA Margin % is 6.56% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sangal Papers (BOM:516096) Overvalued in 2026?
Based on GuruFocus' analysis, Sangal Papers stock appears to be undervalued.
The current stock price of ₹154.80 is trading 15.1% below its estimated GF Value™ of ₹182.32.
GuruFocus considers Sangal Papers to be Modestly Undervalued.
Key valuation signals for BOM:516096:
EBITDA Margin %: 6.56% (58% above median its 10-year median of 4.16)
GF Value™: ₹182.32 vs. price of ₹154.80 (15.1% below fair value)
Industry Position: 3.2% below the Forest Products median (#178 of 283)
No single metric tells the full story. See the BOM:516096 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sangal Papers Ltd is an India-based company. Its main business activity involves the manufacturing and trading of paper and paper products. The company's product line includes envelope papers, ribbed papers, packing and lamination papers, scrapbook and crafts paper, color paper, writing and printing paper, stationery papers, newsprint papers, and others. The company sells its products in India and also exports to international countries, with the majority of its revenue coming from sales within India.
61GF Score
Get the complete analysis for BOM:516096
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:516096 has been successfully added to your 
